What is the appropriate next step in management for a patient who has been non‑weight bearing on the right lower extremity for 4 months after a right ankle injury and now has a DEXA scan showing osteoporosis of the right hip and femoral neck and osteopenia of the left hip and lumbar spine?

Repeat DEXA scan of the contralateral (left) side and spine after resuming weight-bearing to determine if this is true osteoporosis or disuse osteopenia

The most critical next step is to recognize that the right-sided osteoporosis is almost certainly disuse osteopenia from 4 months of non-weight-bearing, not systemic osteoporosis, and you should repeat DEXA imaging after the patient has resumed normal weight-bearing for 3-6 months before initiating pharmacologic treatment.

Understanding the Clinical Context

This patient's DEXA findings show a striking asymmetry: osteoporosis only on the right (immobilized) side with osteopenia on the left hip and spine. This pattern is pathognomonic for disuse osteopenia rather than systemic osteoporosis. Prolonged non-weight-bearing causes rapid, localized bone loss that can reach 1-2% per week in the immobilized limb 1, 2.

Why This Matters for Management

The available guidelines 3, 4, 5 all address systemic osteoporosis where bilateral measurements guide treatment decisions. None specifically address the scenario of unilateral disuse osteopenia, which is a fundamentally different pathophysiologic process that is largely reversible with resumption of weight-bearing 1, 6, 7.

Immediate Management Steps

1. Resume Weight-Bearing (If Ankle Has Healed)

• Initiate immediate protected weight-bearing if the ankle fracture has adequately healed (typically by 4 months)
• Recent high-quality evidence demonstrates that early weight-bearing after ankle fracture fixation is safe and accelerates functional recovery 1, 6, 7, 2
• The INWN trial 1 showed immediate weight-bearing resulted in superior functional outcomes without increased complications
• Disuse bone loss begins reversing within weeks of resumed loading 7

2. Optimize Bone Health During Recovery

While awaiting repeat DEXA, implement non-pharmacologic interventions that all guidelines universally recommend 3, 4:

• Calcium: 1,000-1,200 mg daily (dietary plus supplementation if needed)
• Vitamin D: 800-1,000 IU daily, targeting serum level ≥20 ng/mL (some recommend ≥30 ng/mL)
• Progressive weight-bearing exercise: Essential for reversing disuse osteopenia
• Smoking cessation and alcohol limitation (≤1-2 drinks/day)

3. Repeat DEXA After 3-6 Months of Normal Weight-Bearing

• Allow adequate time for bone remodeling to occur with resumed mechanical loading
• Repeat bilateral hip and spine DEXA to assess:
  • Whether right hip BMD improves (confirming disuse etiology)
  • True baseline BMD now that mechanical loading is normalized
  • Whether left hip osteopenia represents early systemic disease

Decision Algorithm for Pharmacologic Treatment

Only after repeat DEXA with normalized weight-bearing should you consider pharmacologic therapy based on these criteria:

Treat if ANY of the following 3, 4, 5:

• T-score ≤ -2.5 at femoral neck, total hip, or lumbar spine on repeat DEXA
• FRAX 10-year risk: ≥20% for major osteoporotic fracture OR ≥3% for hip fracture
• History of fragility fracture (low-trauma fracture from standing height or less)

First-Line Pharmacologic Treatment (if indicated after repeat DEXA)

Based on the most recent and highest-quality guidelines 3, 4, 5:

Oral bisphosphonates are the preferred first-line agent:

• Alendronate 70 mg weekly or 10 mg daily
• Risedronate 35 mg weekly or 5 mg daily
• Based on efficacy, safety profile, cost, and extensive evidence base

Alternative agents if bisphosphonates contraindicated or not tolerated (in order of preference):

1. IV bisphosphonates (zoledronic acid 5 mg annually)
2. Denosumab 60 mg subcutaneously every 6 months
3. Teriparatide (for severe osteoporosis or very high fracture risk)

Critical Pitfalls to Avoid

Do NOT start bisphosphonates now based on the current DEXA

• The right-sided "osteoporosis" is almost certainly reversible disuse osteopenia
• Starting bisphosphonates prematurely commits the patient to years of therapy that may be unnecessary
• Bisphosphonates have a long skeletal half-life and potential long-term risks (atypical fractures, osteonecrosis of jaw with prolonged use)

Do NOT assume bilateral disease without proper assessment

• The left hip osteopenia and spine osteopenia may represent early systemic disease OR age-appropriate bone density
• FRAX calculation (if patient ≥40 years) incorporating clinical risk factors is essential for determining true fracture risk 4
• Consider secondary causes of osteoporosis: vitamin D deficiency, hyperparathyroidism, hyperthyroidism, celiac disease, medications (especially glucocorticoids)

Do NOT delay mobilization unnecessarily

• Prolonged immobilization beyond what is required for fracture healing causes progressive bone loss 1, 2
• Modern evidence strongly supports early mobilization after ankle fracture fixation 1, 6, 7, 8

Additional Workup to Consider

Before repeat DEXA, obtain:

• Serum 25-hydroxyvitamin D level (treat if <20 ng/mL, optimize to ≥30 ng/mL)
• Basic metabolic panel including calcium, phosphate, alkaline phosphatase
• TSH (hyperthyroidism accelerates bone loss)
• Consider PTH if calcium abnormal
• Review medication list for bone-toxic agents (glucocorticoids, aromatase inhibitors, androgen deprivation therapy, anticonvulsants, PPIs)

Timeline Summary

1. Now: Resume weight-bearing (if ankle healed), optimize calcium/vitamin D, initiate weight-bearing exercise
2. 3-6 months: Repeat bilateral DEXA after normalized mechanical loading
3. After repeat DEXA: Calculate FRAX, determine if pharmacologic treatment indicated based on true systemic bone density

This approach avoids unnecessary pharmacologic treatment while ensuring appropriate intervention if true systemic osteoporosis is present after accounting for the reversible component of disuse osteopenia.